• Home
  • NEW DAY MEDICINE
  • 11 (73) 2024
  • 145 -11 (73) 2024 - K.J. Matmurotov, D.N. Saitov - TREATMENT OF PATIENTS WITH DIABETIC GANGRENA OF THE LEGS ON THE BACKGROUND OF CHRONIC RENAL FAILURE

145 -11 (73) 2024 - K.J. Matmurotov, D.N. Saitov - TREATMENT OF PATIENTS WITH DIABETIC GANGRENA OF THE LEGS ON THE BACKGROUND OF CHRONIC RENAL FAILURE

TREATMENT OF PATIENTS WITH DIABETIC GANGRENA OF THE LEGS ON THE BACKGROUND OF CHRONIC RENAL FAILURE

K.J. Matmurotov - Tashkent Medical Academy

D.N. Saitov - Tashkent Medical Academy

Atajanov T.Sh. - Tashkent Medical Academy

Safarov F.A. - Tashkent Medical Academy

Sapaeva Sh.B. - Tashkent Medical Academy

Resume

Purpose: to improve the results of treatment of patients with diabetic gangrene of the legs against the background of chronic kidney failure (scheduled hemodialysis). Materials and methods: In this research, the results of surgical treatment of 147 patients with diabetic gangrene of the legs on the background of scheduled hemodialysis were analyzed, in which various surgical operations were performed on the legs. The patients underwent inpatient treatment in the purulent surgery department of the multidisciplinary clinic of the Tashkent Medical Academy in 2016-2023. Results: In patients with diabetic gangrene of the legs against the background of chronic renal failure (comparison group (n= 79)), the occlusion of the shin arteries was 58.1%. Hemodynamically significant stenoses in the arterial basins of the calf and joint damage of the leg arteries occur in 25.6% and 16.2%, respectively (r>0.05). Conclusion: In DFS leg gangrene of the paw occurrence and development in etiopathogenesis the paw of the foot arterial little i volume and blood rotation violation to cover opportunity point of view from the point of view , the back is a big ball artery plays a key role because back artery al basin isolated Purulent - necrotic on the foot paw of the process probability of occurrence is equal to 59.9% ( r > 0.05).

Keywords : Diabetes , planned in hemodialysis, chronic kidney in deficiency, diabetic gangrene.

First page

829

Last page

835

For citation:K.J. Matmurotov, D.N. Saitov, Atajanov T.Sh., Safarov F.A., Sapaeva Sh.B. - TREATMENT OF PATIENTS WITH DIABETIC GANGRENA OF THE LEGS ON THE BACKGROUND OF CHRONIC RENAL FAILURE//New Day in Medicine 11(73)2024 829-835 https://https://newdayworldmedicine.com/en/new_day_medicine/11-73-2024

List of References

  1. Матмуротов К.Ж., Саттаров И.С., Қўчқоров А.А., Рузметов Н.А. Влияние микобактериальных ассоциatsiй на кратность повторных оперaций при диабетической гангрене нижних конечностей. //«Вестник» ТМА, 2021;6:106-111.
  2. Матмуротов К.Ж., Саттаров И.С., Атажонов Т.Ш., Саитов Д.Н.. Характер и частота поражения артериальных бассейнов при синдроме диабетической стопы. //«Вестник» ТМА, 2022;1:128-131.
  3. Матмуратов К.Ж., Исмаилов У.С., Атажонов T.Ш., Якубов И.Ю. Разработка методов лечения нейроишемической формы диабетической остеоартропатии при синдроме диабетической стопы. //Проблемы биологии и медицины 2023;5(148).
  4. Matmurotov К.J., Atakov S.S., Sattarov I.S., Otajonov J.H., Atajanov T.Sh. Bone resection features in leg amputation in patients with gangrene of lower extremities on the background of diabetes mellitus. //American Journal of Medicine and Medical Sciences 2019;9(7):249-254.
  5. Babajanov B.D., Matmurotov K.J., Atajоnov T.Sh. The effectiveness of selective intra-arterial catheter therapy in the treatment of diabetic gangrene of the lower extremities. Web of scientist: international. //Scientific research journal. November. 2023;4(11):2776-0979.
  6. Alik Farber, Peter B. Imrey,Thomas S. Huber et al. Multiple preoperative and intraoperative factors predict early fistula thrombosis in the Hemodialysis Fistula Maturation Study. //J Vasc Surg. 2018;63(1):163-170.
  7. Baines C.P. How and when do myocytes die during ischemia and reperfusion: the late phase // J. Cardiovasc. Pharmacol. Ther. 2019;16(3-4):239-243.
  8. Comparison of Removable and Irremovable Walking Boot to Total Contact Casting in Offloading the Neuropathic Diabetic Foot Ulceration / A. Piaggesi, C. Goretti, E. Iacopi [et al.] //Foot Ankle Int. 2021; Apr. 15.
  9. Mandolfino T., Canciglia A., Salibra M. [et al.] Functional outcomes of transmetatarsal amputation in the diabetic foot: timing of revascularization, wound healing and ambulatory status //Updates Surg. 2016;29.
  10. Begun A., Morbach S., Rümenapf G. [et al.] Study of Disease Progression and Relevant Risk Factors in Diabetic Foot Patients Using a Multistate Continuous-Time Markov Chain Model //PLoS One. 2022;11(1):e0147533.
  11. So W., Kuti J.L., Shepard A. [et al.]Tissue penetration and exposure of cefepime in patients with diabetic foot infections //Int. J. Antimicrob Agents. 2019;47(3):247-248.
  12. Zhang Z., Lv L. Effect of local insulin injection on wound vascularization in patients with diabetic foot ulcer //Exp. Ther. Med. 2016;11(2):397-402.
  13. American Diabetes Association. “Standards of medical care in diabetes - 2021”. Diabetes care 43. Suppl 1: s3-s265 http://care.diabetesjournals.org/content/43/Supplement_1/S3.

    file

    download